Stable formulations for lyophilizing therapeutic particles
US8603535B2 · kind B2 · utility
80Cited by
32References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2013 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | Jun 4, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/906
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.